Milestone Scientific

Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. It operates through the following segments: Dental, Medical, and Corporate. The Corporate segment refers to executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities, and public company compliance costs. Its solutions include CompuFlo Epidural, CathCheck Verification System, and Single Tooth Anesthesia System. The company was founded on August 17, 1989 and is headquartered in Roseland, NJ.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

Earnings data Q1 2026

Milestone Scientific reports Q1 revenue, eyes international expansion opportunities

Milestone Scientific's Q1 2024 performance showed revenue over $2.2 million with improved gross margins.
The company's focus on customer relationships and reimbursement strategies is a key strength.
Challenges include revenue decrease and the need for endorsements in the medical space.
Opportunities lie in international expansion, market penetration goals, and increased marketing efforts.

Milestone Scientific reports improved Q2 performance amidst revenue challenges

Milestone Scientific showcased financial improvements in Q2 2024 despite a revenue decrease, with a focus on enhancing operational efficiency and achieving positive cash flow.
The company's strategic partnerships, international expansion plans, and commitment to innovation through intellectual property enhancements signal a path for future growth and market competitiveness.
While facing challenges in revenue generation and operational clarity, Milestone Scientific's strong balance sheet and market positioning offer opportunities for sustained growth and profitability.

Milestone Scientific reports revenue growth and strategic partnerships in Q3

Milestone Scientific shows promising revenue growth and operational improvements in Q3 2024, driven by strong Dental division performance and international sales.
Strategic partnerships and a solid financial position enhance market reach and provide a foundation for future growth.
Challenges include reducing net losses, driving market adoption of CompuFlo, and navigating Medicare coverage expansion, while opportunities exist in reimbursement initiatives and market expansion post-approvals.

Milestone Scientific reports robust Q2 revenue growth and strategic focus

Milestone Scientific delivered strong Q2 2025 performance with revenue growth and improved financial metrics. The company's new leadership team and strategic focus on disciplined execution position it well for future growth. Addressing challenges in medical segment adoption and capitalizing on growth opportunities are key to sustaining momentum.

Milestone Scientific reports stable revenue and strategic growth initiatives

Milestone Scientific's Q3 2025 performance showed stable revenue, cost management efforts, and strategic expansions in the Dental segment. While facing challenges in past sales performance and growth prospects, opportunities exist in optimizing sales strategies and focusing on structured growth. Emphasizing digital marketing and education can drive future utilization and revenue growth.

Milestone Scientific reports improved Q4 performance and eyes international growth

Milestone Scientific's Q4 2025 earnings call showcased improved financial performance, growth prospects in the dental business, and strategic initiatives to drive revenue. The company's focus on CompuFlo adoption, international expansion, and achieving cash flow breakeven by early 2027 reflects a commitment to sustainable growth. Analyst inquiries into reimbursement support, expansion plans, and success metrics indicate areas of interest and potential future developments for Milestone Scientific.